Showing 1 - 5 results of 5 for search 'Giulia Pasello', query time: 0.02s Refine Results
  1. 1
    RadiomiX for Radiomics Analysis: Automated Approaches to Overcome Challenges in Replicability

    RadiomiX for Radiomics Analysis: Automated Approaches to Overcome Challenges in Replicability by Harel Kotler, Luca Bergamin, Fabio Aiolli, Elena Scagliori, Angela Grassi, Giulia Pasello, Alessandra Ferro, Francesca Caumo, Gisella Gennaro

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Liver kinase B1 expression is associated with improved prognosis and tumor immune microenvironment features in small cell lung cancer

    Liver kinase B1 expression is associated with improved prognosis and tumor immune microenvironment features in small cell lung cancer by Alessandro Dal Maso, Federica Ferrarini, Giovanni Esposito, Sonia Anna Minuzzo, Anna Maria Puggia, Federica Pezzuto, Elisabetta Zulato, Loc Carlo Bao, Loc Carlo Bao, Mattia De Nuzzo, Mattia De Nuzzo, Alessandra Ferro, Stefano Frega, Giulia Pasello, Giulia Pasello, Fiorella Calabrese, Matteo Fassan, Matteo Fassan, Federico Rea, Federico Rea, Valentina Guarneri, Valentina Guarneri, Stefano Indraccolo, Stefano Indraccolo, Laura Bonanno, Laura Bonanno

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Estimated direct costs of non‐small cell lung cancer by stage at diagnosis and disease management phase: A whole‐disease model

    Estimated direct costs of non‐small cell lung cancer by stage at diagnosis and disease management phase: A whole‐disease model by Alessandra Buja, Michele Rivera, Anna De Polo, Eugenio di Brino, Marco Marchetti, Manuela Scioni, Giulia Pasello, Alberto Bortolami, Vincenzo Rebba, Marco Schiavon, Fiorella Calabrese, Giovanni Mandoliti, Vincenzo Baldo, PierFranco Conte

    Published 2021-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Baseline levels and dynamic changes of cfDNA, tumor fraction and mutations to anticipate the clinical course of small cell lung cancer (SCLC) patients treated with first-line atezolizumab and chemotherapy: an hypothesis generating study (CATS/ML43257)

    Baseline levels and dynamic changes of cfDNA, tumor fraction and mutations to anticipate the clinical course of small cell lung cancer (SCLC) patients treated with first-line atezo... by Giulia Pasello, Giulia Pigato, Daniela Scattolin, Stefania Lando, Sara Potente, Chiara Romualdi, Anna Roma, Maria Vittoria Resi, Stefano Frega, Alessandra Ferro, Alessandro Dal Maso, Laura Bonanno, Valentina Guarneri, Elisabetta Lazzarini, Stefano Indraccolo

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Carboplatin, etoposide, atezolizumab, and bevacizumab in the first-line treatment of patients with extensive stage small-cell lung cancer: the GOIRC-01-2019 CeLEBrATE study

    Carboplatin, etoposide, atezolizumab, and bevacizumab in the first-line treatment of patients with extensive stage small-cell lung cancer: the GOIRC-01-2019 CeLEBrATE study by Marcello Tiseo, Corrado Ficorella, Andrea Ardizzoni, Carlo Genova, Francesca Mazzoni, Giuseppe Lamberti, Luca Boni, Ida Colantonio, Alessandro Leonetti, Saverio Cinieri, Andrea Bonetti, Michele Tognetto, Federica Bertolini, Alessandro Follador, Elisa Andrini, Antonio Frassoldati, Francesco Gelsomino, Giulia Pasello, Karim Rihawi, Ferdinando Riccardi, Donatella Giardina, Matteo Brighenti

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: